Resources & Information

Nov 3 2014

From our readers…

Comments:   0 comments  Print Friendly Version  |   Share this item
A reader of the email edition of the Summer 2014 Forum took issue with the fact the article, “Hepatitis C: everyone deserves a chance at a cure,” did not discuss the cost of treatment. We asked the author, Michael C. Fried, MD, to address this concern. Here is Dr. Fried’s response:

“The true costs of treatment are difficult to characterize since many factors affect final drug pricing for the payers and patients. A 12-week course of Sofosbuvir costs approximately $84,000. The cost for the newest all-oral medication has not been released (These drugs won’t be approved for another few weeks). With such high rates of cure, the costs of these medications must be weighed against the myriad benefits of cure for those patients living with HCV infection.”

 No Comments on this article

 Post a comment on this article
Please do not include links to external websites in your comment. Please limit comments to no more than 300 words. The NCMB reserves the right to edit comments to meet the length limit. Abusive or profane remarks and personal attacks will not be published. The editor will make every effort to review and post comments in a timely fashion.